Zurbau, Andreea
Jenkins, Alexandra L.
Jovanovski, Elena
Au-Yeung, Fei
Bateman, Emma A.
Brissette, Christy
Wolever, Thomas M. S.
Hanna, Amir
Vuksan, Vladimir
Article History
Received: 1 February 2017
Revised: 9 February 2018
Accepted: 12 February 2018
First Online: 17 May 2018
Compliance with ethical standards
:
: ALJ is part owner and vice-president of Glycemic Index laboratories, Inc., (GI Labs) a contract research organization. AZ and FA-Y are contract research assistants for GI labs. TMSW and his wife receive payment as Officers and part owners of GI Lab. However, neither they, nor GI Labs, have any financial interest in any intellectual property developed as a result of research done at GI Labs, and have no equity in companies which produce or sell food products. VV was vice-president and partial owner of GI Labs from 2004 until 2015. He acted as a consultant to Salba Corporation, Buena Aires, Argentina (2003-2006), Core Naturals, FL, USA (2007–2008) and received conference travel grants from Salba Smart Natural Products (2008 and 2010), LLC, Centennial, CO, USA, and Source Salba Inc, Toronto, Canada (2008). VV holds an American (no. 7,326,404 B2) and Canadian (no. 2,410,556) patent for use of viscous fiber blend in diabetes, metabolic syndrome and cholesterol lowering; received a honorarium for a scientific advice from InovoBiologic (Calgary, AB., Canada) the producer of viscous fiber blend PGX® that is developed based on his patent. The remaining authors declare that they have no conflict of interest.